We are pleased to present the 2021 Mid-Year Technology and Life Sciences IPO Report, which provides analyses related to the pricing of 123 initial public offerings completed by U.S.-based technology and life sciences companies between January 1 and June 30, 2021. The report includes IPO filing, pricing, and value statistics; governance details; ownership and structure factors; and defensive measure data points. It also briefly discusses concurrent private placements, indications of interest, direct listings, and SPACs.

Click here to read the report.